A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancerRIXE, Olivier; FRANCO, Sandra X; YARDLEY, Denise A et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 6, pp 1139-1148, issn 0344-5704, 10 p.Article

Ductal Carcinoma in Situ : State of the Science and Roadmap to Advance the FieldKUERER, Henry M; ALBARRACIN, Constance T; BABIERA, Gildy et al.Journal of clinical oncology. 2009, Vol 27, Num 2, pp 279-288, issn 0732-183X, 10 p.Article

Predictors of Contralateral Breast Cancer in Patients With Unilateral Breast Cancer Undergoing Contralateral Prophylactic MastectomyMIN YI; MERIC-BERNSTAM, Funda; MIDDLETON, Lavinia P et al.Cancer. 2009, Vol 115, Num 5, pp 962-971, issn 0008-543X, 10 p.Article

Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case―control studyWANG, Li-E; HAN, Chan H; PING XIONG et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 1147-1155, issn 0167-6806, 9 p.Article

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutationsBAYRAKTAR, Soley; GUTIERREZ-BARRERA, Angelica M; HORTOBAGYI, Gabriel N et al.Breast cancer research and treatment. 2011, Vol 130, Num 1, pp 145-153, issn 0167-6806, 9 p.Article

Phase 3 Study Comparing the Use of Docetaxel on an Every-3-week Versus Weekly Schedule in the Treatment of Metastatic Breast CancerRIVERA, Edgardo; MEJIA, Jaime A; VALERO, Vicente et al.Cancer. 2008, Vol 112, Num 7, pp 1455-1461, issn 0008-543X, 7 p.Article

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massKUERER, Henry M; LARI, Sara A; LITTON, Jennifer K et al.Breast cancer research and treatment. 2012, Vol 133, Num 3, pp 1131-1141, issn 0167-6806, 11 p.Article

Early Onset HER2-Positive Breast Cancer Is Associated With Germline TP53 MutationsMELHEM-BERTRANDT, Amal; BOJADZIEVA, Jasmina; ARUN, Banu K et al.Cancer. 2012, Vol 118, Num 4, pp 908-913, issn 0008-543X, 6 p.Article

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutationsSCHMELER, Kathleen M; SUN, Charlotte C; PETERSON, Susan K et al.Obstetrics and gynecology (New York. 1953). 2006, Vol 108, Num 3, pp 515-520, issn 0029-7844, 6 p., 1Article

Perception of Screening and Risk Reduction Surgeries in Patients Tested for a BRCA Deleterious MutationLITTON, Jennifer K; WESTIN, Shannon N; ARUN, Banu K et al.Cancer. 2009, Vol 115, Num 8, pp 1598-1604, issn 0008-543X, 7 p.Article

Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast CancerATCHLEY, Deann P; ALBARRACIN, Constance T; LOPEZ, Adriana et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4282-4288, issn 0732-183X, 7 p.Article

A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumorsGARLAND, Linda L; HIDALGO, Manuel; MENDELSON, David S et al.Clinical cancer research. 2006, Vol 12, Num 14, pp 4274-4282, issn 1078-0432, 9 p., 1Article

Earlier Age of Onset of BRCA Mutation-Related Cancers in Subsequent GenerationsLITTON, Jennifer K; READY, Kaylene; ARUN, Banu K et al.Cancer. 2012, Vol 118, Num 2, pp 321-325, issn 0008-543X, 5 p.Article

Effectiveness of Alternating Mammography and Magnetic Resonance Imaging for Screening Women With Deleterious BRCA Mutations at High Risk of Breast CancerLE-PETROSS, Huong T; WHITMAN, Gary J; ATCHLEY, Deanne P et al.Cancer. 2011, Vol 117, Num 17, pp 3900-3907, issn 0008-543X, 8 p.Article

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast CancerGONZALEZ-ANGULO, Ana M; TIMMS, Kirsten M; HORTOBAGYI, Gabriel N et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 1082-1089, issn 1078-0432, 8 p.Article

Satisfaction With Ovarian Carcinoma Risk-Reduction Strategies Among Women at High Risk for Breast and Ovarian CarcinomaWESTIN, Shannon N; SUN, Charlotte C; BODURKA, Diane C et al.Cancer. 2011, Vol 117, Num 12, pp 2659-2667, issn 0008-543X, 9 p.Article

The functional promoter polymorphism ( — 842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and youngerHAN, Chan H; JIACHUN LU; QINGYI WEI et al.Breast cancer research and treatment. 2010, Vol 122, Num 1, pp 243-249, issn 0167-6806, 7 p.Article

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy : Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancerBUZDAR, Aman U; IBRAHIM, Nuhad K; CRISTOFANILLI, Massimo et al.Journal of clinical oncology. 2005, Vol 23, Num 16, pp 3676-3685, issn 0732-183X, 10 p.Article